Sol-Gel Technologies - 53 Year Dividend History | SLGL
Historical dividend payout and yield for Sol-Gel Technologies (SLGL) since 1971. The current TTM dividend payout for Sol-Gel Technologies (SLGL) as of November 21, 2024 is $0.00. The current dividend yield for Sol-Gel Technologies as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.015B |
$0.002B |
|
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
